Brevan Howard Capital Management LP Denali Therapeutics Inc. Transaction History

Brevan Howard Capital Management LP

  • $17 Billion
  • Q3 2025

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$20.24 - $31.58 $136,741 - $213,354
6,756 Added 60.53%
17,917 $365,000
Q3 2024

Nov 14, 2024
SELL
$20.96 - $31.05 $381,388 - $564,985
-18,196 Reduced 61.98%
11,161 $325,000
Q2 2024

Aug 14, 2024
BUY
$14.96 - $23.22 $439,180 - $681,669
29,357 New
29,357 $681,000

Others Institutions Holding DNLI

# of Institutions
262
Shares Held
134M
Call Options Held
219K
Put Options Held
107K
View Full List

About Denali Therapeutics Inc.

DNLI Quotes by TradingView
  • Ticker DNLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 134,174,000
  • Market Cap $2.34B
  • Description
  • Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...
More about DNLI
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email